← Back to guidelines
Dermatology3 papers

Non-Hodgkin's lymphoma of skin

Last edited: 4/15/2026

Overview

Non-Hodgkin's lymphoma (NHL) of the skin involves malignant lymphocytes primarily affecting cutaneous tissues, manifesting as various skin lesions that can be clinically diverse 1.

Diagnosis

  • Histopathological examination: Essential for definitive diagnosis, often requiring high-resolution images for accurate assessment 1.
  • Immunohistochemistry: Utilized to identify specific lymphocyte subtypes and aid in classification 1.
  • Flow cytometry: Provides additional diagnostic information, particularly useful in distinguishing between reactive and neoplastic processes 1.
  • Biomarker analysis: Includes genetic testing for specific translocations or mutations to guide prognosis and treatment 1.
  • Management

  • First-line treatments:
  • - Localized disease: Radiation therapy is often used 1. - Systemic involvement: Chemotherapy regimens such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) may be indicated 1.
  • Adjunctive therapies:
  • - Targeted therapies: Depending on specific molecular markers, drugs like rituximab for B-cell lymphomas 1. - Immunotherapy: Emerging role for immune checkpoint inhibitors in certain subtypes 1.

    Special Populations

  • Pregnancy: Management strategies need to balance maternal and fetal safety; often involves close monitoring and individualized treatment plans 1.
  • Elderly: Treatment approaches may be modified to account for comorbidities and reduced tolerance to aggressive therapies 1.
  • Key Recommendations

  • Utilize high-resolution histopathological imaging for accurate diagnosis of cutaneous NHL (Evidence: Expert opinion 1).
  • Incorporate immunohistochemistry and flow cytometry to refine subtype classification (Evidence: Expert opinion 1).
  • Tailor treatment based on disease extent and patient-specific factors, considering localized radiation for skin-limited disease and systemic chemotherapy for disseminated disease (Evidence: Expert opinion 1).
  • References

    1 Feit J, Kempf W, Jedlicková H, Burg G. Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. Journal of cutaneous pathology 2005. link

    Original source

    1. [1]
      Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin.Feit J, Kempf W, Jedlicková H, Burg G Journal of cutaneous pathology (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG